Nanil Therapeutics Inc. is an active federal corporation (corporation number 16715940). Its business number is 720648021. It was formed on Feb 2, 2025 under the Canada Business Corporations Act and its registered office is in Toronto, Ontario. Its annual returns are up to date, most recently for 2026. It has one director on record.
Corporate details
- Corporation number
- 16715940
- Business number
- 720648021
- Status
- Active
- Governing law
- Canada Business Corporations Act
- Formed
- Feb 2, 2025
- Registered office
- 36 Toronto St
Suite 850
Toronto ON M5C 2C5 - Number of directors
- At least 1, at most 10As the articles allow.
Annual filings
- Anniversary date
- Feb 2The date of incorporation, amalgamation or continuance.
- Annual filing period
- Feb 2 to Apr 3 each year
- Last annual meeting
- Apr 1, 2026
| Year | Annual return | Annual meeting |
|---|---|---|
| 2026 | Filed |
The last annual return filed, and each year since.
Directors
Loading the directors from the federal record...
Federal grants and contributions
2 agreements since 2025, worth $150,000 in all.
| Department | Program | Value | Starts |
|---|---|---|---|
| National Research Council Canada | biologics design using AI | $75,000 | Jan 12, 2026 |
| National Research Council Canada | POC of AI-Nano-antibody design and Validation for AD | $75,000 | Sep 1, 2025 |
As each federal department publishes them (proactive disclosure). A value is the agreement's total as last amended; the money may be paid over several years. Search every federal grant.
Registered in a province as well? Find provincial registrations(opens in a new tab). Something wrong or out of date? Request a correction.